504 related articles for article (PubMed ID: 32243703)
1. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
[TBL] [Abstract][Full Text] [Related]
2. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
3. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
[TBL] [Abstract][Full Text] [Related]
4. Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study.
Kasai Y; Kessoku T; Tanaka K; Yamamoto A; Takahashi K; Kobayashi T; Iwaki M; Ozaki A; Nogami A; Honda Y; Ogawa Y; Kato S; Imajo K; Higurashi T; Hosono K; Yoneda M; Usuda H; Wada K; Kawanaka M; Kawaguchi T; Torimura T; Kage M; Hyogo H; Takahashi H; Eguchi Y; Aishima S; Kobayashi N; Sumida Y; Honda A; Oyamada S; Shinoda S; Saito S; Nakajima A
Clin Transl Gastroenterol; 2022 Jul; 13(7):e00503. PubMed ID: 35616321
[TBL] [Abstract][Full Text] [Related]
5. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
6. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease.
Petrov PD; García-Mediavilla MV; Guzmán C; Porras D; Nistal E; Martínez-Flórez S; Castell JV; González-Gallego J; Sánchez-Campos S; Jover R
Mol Nutr Food Res; 2019 Oct; 63(20):e1900487. PubMed ID: 31322321
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
8. Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model.
Hamid H; Zhang JY; Li WX; Liu C; Li ML; Zhao LH; Ji C; Ma QG
Poult Sci; 2019 Jun; 98(6):2509-2521. PubMed ID: 30690636
[TBL] [Abstract][Full Text] [Related]
9. Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota.
Zhang Y; Qi H; Wang L; Hu C; Gao A; Wu Q; Wang Q; Lin H; Chen B; Wang X; Wang S; Lin H; Wang W; Bi Y; Wang J; Lu J; Liu R
J Diabetes; 2023 Feb; 15(2):165-180. PubMed ID: 36682739
[TBL] [Abstract][Full Text] [Related]
10. Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial.
Wan Y; Yuan J; Li J; Li H; Zhang J; Tang J; Ni Y; Huang T; Wang F; Zhao F; Li D
Clin Nutr; 2020 Feb; 39(2):395-404. PubMed ID: 30876827
[TBL] [Abstract][Full Text] [Related]
11. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
Nimer N; Choucair I; Wang Z; Nemet I; Li L; Gukasyan J; Weeks TL; Alkhouri N; Zein N; Tang WHW; Fischbach MA; Brown JM; Allayee H; Dasarathy S; Gogonea V; Hazen SL
Metabolism; 2021 Mar; 116():154457. PubMed ID: 33275980
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease.
Shi Z; Chen G; Cao Z; Wu F; Lei H; Chen C; Song Y; Liu C; Li J; Zhou J; Lu Y; Zhang L
J Agric Food Chem; 2021 Apr; 69(13):3982-3991. PubMed ID: 33755449
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD.
Smirnova E; Muthiah MD; Narayan N; Siddiqui MS; Puri P; Luketic VA; Contos MJ; Idowu M; Chuang JC; Billin AN; Huss RS; Myers RP; Boyett S; Seneshaw M; Min HK; Mirshahi F; Sanyal AJ
Hepatology; 2022 Dec; 76(6):1811-1824. PubMed ID: 35561146
[TBL] [Abstract][Full Text] [Related]
14. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
Jahnel J; Zöhrer E; Alisi A; Ferrari F; Ceccarelli S; De Vito R; Scharnagl H; Stojakovic T; Fauler G; Trauner M; Nobili V
J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):85-90. PubMed ID: 25729888
[TBL] [Abstract][Full Text] [Related]
15. Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease.
Fitzinger J; Rodriguez-Blanco G; Herrmann M; Borenich A; Stauber R; Aigner E; Mangge H
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257143
[TBL] [Abstract][Full Text] [Related]
16. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
[TBL] [Abstract][Full Text] [Related]
17. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
Puri P; Daita K; Joyce A; Mirshahi F; Santhekadur PK; Cazanave S; Luketic VA; Siddiqui MS; Boyett S; Min HK; Kumar DP; Kohli R; Zhou H; Hylemon PB; Contos MJ; Idowu M; Sanyal AJ
Hepatology; 2018 Feb; 67(2):534-548. PubMed ID: 28696585
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
[TBL] [Abstract][Full Text] [Related]
19. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.
Caussy C; Hsu C; Singh S; Bassirian S; Kolar J; Faulkner C; Sinha N; Bettencourt R; Gara N; Valasek MA; Schnabl B; Richards L; Brenner DA; Hofmann AF; Loomba R
Aliment Pharmacol Ther; 2019 Jan; 49(2):183-193. PubMed ID: 30506692
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.
Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T
mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
